Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 241 (RNA5SP241) is a human gene annotated as a pseudogene of the 5S ribosomal RNA gene. Pseudogenes are genetic elements that resemble canonical genes but have lost their protein-coding or functional capacity as a result of mutations or genomic rearrangements[2][3][4][6]. There are several classes of pseudogenes, including processed and unprocessed types; RNA5SP241 belongs to the "rRNA pseudogene" class, which means it is a non-functional copy of a gene encoding ribosomal RNA[6]. Unlike functional 5S rRNA genes, which produce an essential component of the large ribosomal subunit, this pseudogene does not contribute functionally to ribosome structure or protein synthesis and does not encode a protein product[2][3][6]. There is no evidence for a role in disease, drug interaction, or utility as a biomarker. Some pseudogenes can regulate other genes or RNAs, but no such function has been assigned to RNA5SP241[4]. Key clarifications: - This is not a protein, enzyme, receptor, transporter, or classical therapeutic target; it is a non-coding pseudogene[2][3][6]. - The designation as a "target" is incorrect for drug discovery or therapeutic applications. - There are no known aliases in clinical/therapeutic contexts, interacting drugs, or mechanisms of action. - Any connection between this pseudogene and disease is speculative and unsupported by current curated knowledge[2][3][4]. Summary for structuring: This gene is a non-coding RNA pseudogene—not a validated or potential drug target, with no therapeutically relevant properties or disease associations.
None (no drugs or small molecules known to act on this pseudogene)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 241 (RNA5SP241).